BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30654077)

  • 1. Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.
    Hawkins ML; Rioth MJ; Eguchi MM; Cockburn M
    J Am Acad Dermatol; 2019 Jun; 80(6):1640-1649. PubMed ID: 30654077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of mucosal melanoma survival in a population-based setting.
    Altieri L; Eguchi M; Peng DH; Cockburn M
    J Am Acad Dermatol; 2019 Jul; 81(1):136-142.e2. PubMed ID: 30296542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014.
    Claeson M; Gillstedt M; Whiteman DC; Paoli J
    Acta Derm Venereol; 2017 Nov; 97(10):1206-1211. PubMed ID: 28761961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
    McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
    Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic groups of patients with stage I melanoma.
    Kuehnl-Petzoldt C; Wiebelt H; Berger H
    Arch Dermatol; 1983 Oct; 119(10):816-9. PubMed ID: 6614950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial.
    Eggermont AMM; Rutkowski P; Dutriaux C; Hofman-Wellenhof R; Dziewulski P; Marples M; Grange F; Lok C; Pennachioli E; Robert C; van Akkooi ACJ; Bastholt L; Minisini A; Marshall E; Salès F; Grob JJ; Bechter O; Schadendorf D; Marreaud S; Kicinski M; Suciu S; Testori AAE
    Eur J Cancer; 2020 Jul; 133():94-103. PubMed ID: 32470710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
    Green AC; Baade P; Coory M; Aitken JF; Smithers M
    J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.
    Paver EC; Ahmed T; Burke H; Saw RPM; Stretch JR; Spillane AJ; Shannon KF; Vergara IA; Elder DE; Lo SN; Thompson JF; Scolyer RA
    JAMA Dermatol; 2023 Dec; 159(12):1359-1367. PubMed ID: 37910123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
    Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
    Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of ulceration of cutaneous melanoma.
    Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
    Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.
    In 't Hout FE; Haydu LE; Murali R; Bonenkamp JJ; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jun; 255(6):1165-70. PubMed ID: 22566014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
    Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
    J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
    Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
    Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
    Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulceration and prognosis in cutaneous malignant melanoma.
    McGovern VJ; Shaw HM; Milton GW; McCarthy WH
    Histopathology; 1982 Jul; 6(4):399-407. PubMed ID: 7118080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
    Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
    JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.